Cargando…
A cohort study to evaluate cardiovascular risk of selective and nonselective cyclooxygenase inhibitors (COX-Is) in arthritic patients attending orthopedic department of a tertiary care hospital
BACKGROUND: Cyclooxygenase-2 inhibitors (COX-2-Is) have recently been concerned in the occurrence of adverse cardiovascular (CV) events. Rofecoxib and valdecoxib has been withdrawn from the market, but celecoxib, etoricoxib and parecoxib continues to be used. Other nonsteroidal anti-inflammatory dru...
Autores principales: | Bhosale, Uma A., Quraishi, Nilofar, Yegnanarayan, Radha, Devasthale, Dileep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178340/ https://www.ncbi.nlm.nih.gov/pubmed/25298608 http://dx.doi.org/10.4103/0300-1652.140386 |
Ejemplares similares
-
Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2012) -
Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2008) -
Postoperative pharmacodynamic interaction of ondansetron; a 5-HT3 antagonist and paracetamol in patients operated in the ENT department under local anesthesia
por: Bhosale, Uma A., et al.
Publicado: (2014) -
Attitude, perception and feedback of second year medical students on teaching–learning methodology and evaluation methods in pharmacology: A questionnaire-based study
por: Bhosale, Uma A., et al.
Publicado: (2013) -
Effect of aqueous extracts of Achyranthes aspera Linn. on experimental animal model for inflammation
por: Bhosale, Uma A., et al.
Publicado: (2012)